Feng Xu

SVP, Biometrics

Feng Xu is a seasoned biostatistician with over 20 years of experience in clinical development, including four successful global filings. Before joining Artiva, he served as Vice President, Head of Biometrics at IGM Biosciences and Rain Oncology, where he led biometrics activities for multiple Phase 1/2/3 trials in oncology and autoimmune diseases. Prior to that, he held roles of increasing responsibility at Puma Biotechnology, including VP, Head of Biostatistics. Feng began his career in drug development at Amgen, where he served as the lead biostatistician for multiple pivotal clinical trials in inflammation, oncology, and cardiovascular disease. He holds an M.S. in biostatistics from Columbia University.